VIR-2482 (1200 mg)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza ANCT05567783VIRPhase 2Terminated2023-05-05Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.